Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2015-05-08
- Last Posted Date
- 2017-02-28
- Lead Sponsor
- Gynecologic Oncology Associates
- Target Recruit Count
- 30
- Registration Number
- NCT02437812
- Locations
- ๐บ๐ธ
Gynecologic Oncology Associates, Newport Beach, California, United States
Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-09-12
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Gynecologic Oncology Associates
- Target Recruit Count
- 20
- Registration Number
- NCT01432015
- Locations
- ๐บ๐ธ
Gynecologic Oncology Associates, Newport Beach, California, United States
Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma
- First Posted Date
- 2009-09-14
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- Gynecologic Oncology Associates
- Target Recruit Count
- 18
- Registration Number
- NCT00976183
- Locations
- ๐บ๐ธ
Gynecologic Oncology Associates, Newport Beach, California, United States
Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients
- First Posted Date
- 2005-08-09
- Last Posted Date
- 2015-03-10
- Lead Sponsor
- Gynecologic Oncology Associates
- Target Recruit Count
- 20
- Registration Number
- NCT00127920
- Locations
- ๐บ๐ธ
Gynecologic Oncology Associates, Newport Beach, California, United States
๐บ๐ธFlorida Hospital College of Health Sciences, Orlando, Florida, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath